Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 2—February 2026
Research Letter
Multicenter Serologic Investigation of Influenza D Virus in Cats and Dogs, Europe, 2015–2024
Table 1
Overview of samples, including country, year of collection, testing assays, IDV strains, and other information, analyzed for multicenter serologic investigation of IDV in cats and dogs, Europe, 2015–2024*
| Animal species | Country | No. samples (type) | Year of collection | Assay | IDV strain | Other tests or assays |
|
|---|---|---|---|---|---|---|---|
| Cat |
France | 47 (serum) | 2015–2018 | HI | D/OK | ICV HI, IAV NP ELISA | |
| Italy | 132 (serum) | 2023–2024 | HI | D/OK, D/660 | None | ||
| Ukraine |
118 (serum) |
2020–2023–2024 |
HI |
D/OK, D/660 |
None |
||
| Dog | France | 114 (serum), 41 (nasal swab), 24 (lung fragment) | 2015–2018 | HI, qRT-PCR | D/OK | ICV HI, IAV NP ELISA | |
| Ukraine | 122 (serum) | 2020–2023–2024 | HI | D/OK, D/660 | IAV NP ELISA |
||
*HI, hemagglutination inhibition; IAV NP ELISA, influenza A virus antibodies by nucleoprotein ELISA; ICV, influenza C virus; IDV, influenza D virus, qRT-PCR, real-time reverse transcription PCR.
1These authors contributed equally to this article.
Page created: December 31, 2025
Page updated: February 12, 2026
Page reviewed: February 12, 2026
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.